IMIBE Institut für Medizinische Informatik, Biometrie und Epidemiologie

What IMIBE Institut für Medizinische Informatik, Biometrie und Epidemiologie does

IMIBE (Institut für Medizinische Informatik, Biometrie und Epidemiologie) is a university research institute operating within the Universitätsklinikum Essen (AöR), a German public-law hospital entity headquartered at Zweigertstr. 37, 45130 Essen. The institute is structured around five research departments — Medical Informatics, Clinical Epidemiology, Medical Documentation, Population-Based Epidemiology, and Biometry & Bioinformatics — supplemented by a Department of Prevention and Health Promotion. Its stated mission is the planning, conduct, and evaluation of epidemiological and patient-oriented research projects aimed at identifying health risk and protective factors, developing prevention measures, and improving early detection, diagnostics, and therapy.

The institute's service portfolio spans academic research, doctoral training, and applied clinical support. Core offerings include the Zentrum für Klinische Studien Essen (ZKSE), which provides co-operating scientists with support across clinical and epidemiological study design, conduct, and analysis; a PhD program in 'Epidemiology and Clinical Research', now in its tenth year; biometric consulting for study design and statistical analysis; and a CAC Score tool for cardiovascular risk stratification. IMIBE participates in major long-term cohort studies including NAKO (German National Cohort) and the Heinz Nixdorf Recall and Mehrgenerationenstudien, and operates the Clinical Cancer Registry and Follow-Up Center. A newer line is the Innovationsfonds-funded PREFO project linking cancer registry, statutory health insurance, and rehabilitation data for oncological care research in North Rhine-Westphalia.

IMIBE is not a commercial entity. It has 22 employees, no disclosed revenue, and no commercial pricing model; services are delivered through the parent university hospital, academic collaborations, and publicly funded research grants. Leadership is provided by Univ.-Prof. Dr. med. Andreas Stang, MPH, as director. The institute's primary 'customers' are internal clinicians at Universitätsklinikum Essen and collaborating academic scientists, with its outreach channeled through the Universitätsmedizin Essen social media presence on Facebook, Instagram, and YouTube.

Name

IMIBE Institut für Medizinische Informatik, Biometrie und Epidemiologie

Legal name

Institut für Medizinische Informatik, Biometrie und Epidemiologie

Website

https://imibe.de

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

IMIBE is a university research institute within Universitätsklinikum Essen (Germany) conducting epidemiological, biometric, and medical informatics research across five departments, operating a clinical trials center (ZKSE), running a PhD program, and managing cohort studies and a clinical cancer registry.

Ownership category

akta.pro rank

Product category

Academic Medical Research Services

NAICS

Research and Development in the Social Sciences and Humanities (541720), Research and Development in the Social Sciences and Humanities (54172), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)

akta.pro industry

PRIMARYHLAGAEAI

Sample Logistics, Biorepository & IVD Kit Management (Trial Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

• Medical informatics research
• Epidemiological studies
• Biostatistical consulting
• Clinical trial support
• Population health research

Headquarters

HQ city

Essen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Marketing channels1 record

Core offering

IMIBE is an interdisciplinary university research institute that plans, conducts, and evaluates epidemiological and patient-oriented research projects to identify health risk and protective factors, develop prevention measures, and improve early detection, diagnostics, and therapy. It operates five research departments (Medical Informatics, Clinical Epidemiology, Medical Documentation, Population-Based Epidemiology, and Biometry & Bioinformatics) and runs the Zentrum für Klinische Studien Essen (ZKSE), which provides clinical study support to collaborating scientists.

Product overview

IMIBE is a university research institute at Universitätsklinikum Essen organized as a platform spanning five research departments (Medical Informatics, Clinical Epidemiology, Medical Documentation, Population-Based Epidemiology, and Biometry & Bioinformatics). The core research institute serves as the central product, supplemented by four distinct sub-offerings: the Clinical Studies Center Essen (ZKSE) for clinical trial support, the PhD Program in Epidemiology and Clinical Research for doctoral education, the CAC Score tool for cardiovascular risk assessment, and Biometric Consulting services. The institute's offerings are interconnected: the five departments provide the methodological foundation for the clinical trials center, doctoral training, and external consulting services, while the ZKSE acts as the operational hub for co-operating scientists conducting clinical and epidemiological studies.

Differentiator

Problem solved

Functional benefit

Products and services

• IMIBE Forschungsinstitut (IMIBE Research Institute) Core research institute spanning five departments that plans, conducts, and evaluates epidemiological and patient-oriented research projects. Serves clinical researchers, epidemiologists, and medical professionals requiring methodological expertise in medical informatics, biometry, and epidemiology.
• Zentrum für Klinische Studien Essen (ZKSE) - Clinical Studies Center Essen Dedicated clinical trials center providing co-operating scientists with support across multiple areas of clinical and epidemiological studies, including study design, implementation, and analysis.
• PhD-Programm "Epidemiology and Clinical Research" Doctoral training program developing junior researchers in epidemiology and clinical research, offering structured curriculum, scholarships, and supervised research training.
• CAC Score Cardiovascular risk assessment tool providing coronary artery calcium (CAC) scoring for early detection and risk stratification of cardiovascular disease, based on research from the Heinz Nixdorf Recall Study.
• Biometrische Beratung (Biometric Consulting) Biometric consulting services offered to researchers and scientists for study design, statistical analysis, and data evaluation in clinical and epidemiological studies.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• Universitätsklinikum Essen (AöR)coreStrategic or Co-development PartnerIMIBE is an institute under the Universitätsmedizin Essen umbrella. The institute operates within the university hospital system and collaborates with the main hospital on research projects and clinical studies.
• NAKO - Die GesundheitsstudiecoreStrategic or Co-development PartnerIMIBE participates in NAKO, the German National Cohort - one of the largest population-based health studies worldwide, investigating the causes of major chronic diseases.
• Heinz Nixdorf Recall StudiecoreStrategic or Co-development PartnerLong-term epidemiological study investigating the causes of coronary heart disease and heart attacks, conducted in collaboration with IMIBE researchers.
• Heinz Nixdorf MehrgenerationenstudiecoreStrategic or Co-development PartnerMulti-generational follow-up study extending the Heinz Nixdorf Recall Study to examine hereditary factors and family patterns in cardiovascular disease.
• Klinisches Krebsregister und Follow-Up CentercoreStrategic or Co-development PartnerIMIBE operates the Clinical Cancer Registry and Follow-Up Center, collecting and analyzing cancer data for research and quality assurance purposes.
• Zentrum für Klinische Studien Essen (ZKSE)coreStrategic or Co-development PartnerIMIBE's Center for Clinical Studies provides support to cooperating scientists in various areas of clinical and epidemiological studies.
• PREFO Project (Innovationsfonds)minorStrategic or Co-development PartnerInnovation Fund-funded project on consequences of cancer based on linkage of cancer registry, health insurance and rehabilitation data in North Rhine-Westphalia.

Recent moves6 records

Expansion highlights4 records

Direct peers

• Koordinierungszentren für Klinische Studien (KKS Netzwerk): Germany's network of academic clinical trial coordination centers mirrors IMIBE's ZKSE in providing clinical study design, conduct, and analysis support to academic investigators across university hospitals.
• Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI), Universitätsmedizin Mainz: IMBEI is the closest German peer: a university research institute with the same triple focus on medical informatics, biometrics, and epidemiology. Its mission, structure (departments covering biometry, epidemiology, and informatics), and university hospital embedding mirror IMIBE's positioning.
• Institut für Medizinische Informatik, Biometrie und Epidemiologie, LMU München: Direct peer with identical institutional name and scope at LMU Munich, conducting clinical epidemiology, biometry, and medical informatics research for a university hospital.
• Institut für Medizinische Epidemiologie, Biometrie und Informatik (IMEBI), Universität Halle: University institute with the same combined epidemiology/biometry/informatics remit, supporting clinical and population-based research at a German university hospital.
• Institut für Medizinische Biometrie und Statistik, Universität Freiburg: Freiburg's institute for medical biometry and statistics provides methodological and statistical support to clinical researchers, comparable to IMIBE's biometric consulting and study support functions.
• Leibniz-Institut für Präventionsforschung und Epidemiologie (BIPS): Non-university research institute focused on epidemiological methods, prevention research, and population health, with overlapping methodological focus on cohort studies and biostatistics relevant to IMIBE's research.

Broad incumbents

• Robert Koch-Institut (RKI): Germany's federal government agency for disease control and public health. Conducts large-scale epidemiological surveillance and population studies, providing a broader institutional counterpoint to IMIBE's research scope.

Emerging players

• Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG): Germany's HTA agency applies biostatistical and epidemiological methods to assess healthcare interventions, with overlapping methodological expertise in evidence synthesis and clinical research evaluation.

Regional players

• Westdeutsches Tumorzentrum (WTZ) Essen: Regional oncology center at the same Universitätsmedizin Essen campus, collaborating with IMIBE on cancer registry and clinical studies in North Rhine-Westphalia.

Others

• NAKO e.V. (German National Cohort Study Center): Central coordinating entity for the NAKO study in which IMIBE participates. Serves as the infrastructure backbone and funder counterpart to IMIBE's contribution to the cohort.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCtrJZc2C2gYxOwBaG1EzAeg
• Facebookfacebook.com/ukessen
• Instagraminstagram.com/universitaetsmedizinessen
• LinkedInlinkedin.com/company/imibe-institut-f%C3%BCr-medizinische-informatik-biometrie-und-epidemiologie

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IMIBE Institut für Medizinische Informatik, Biometrie und Epidemiologie